Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NEOG | US
-0.34
-3.91%
Healthcare
Diagnostics & Research
31/08/2024
20/03/2026
8.36
8.70
8.71
8.24
Neogen Corporation together with its subsidiaries develops manufactures and markets various products for food and animal safety worldwide. It operates through two segments Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed including foodborne pathogens spoilage organisms natural toxins food allergens genetic modifications ruminant by-products meat speciation drug residues pesticide residues and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies crackers candy ice cream and other processed foods; meat and poultry processors seafood processors fruit and vegetable producers and dairies; laboratories; and producers of pharmaceuticals cosmetics and veterinary vaccines. The Animal Safety segment provides veterinary instruments pharmaceuticals vaccines topicals parasiticides diagnostic products rodenticides cleaners disinfectants insecticides and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria fungi and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing Michigan.
View LessLow Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
53.9%1 month
43.5%3 months
73.7%6 months
68.3%-
16.00
1.00
0.28
0.20
23.77
4.28
0.66
179.54M
1.81B
1.81B
-
3.40
-85.60
-5.30
-0.75
15.75
12.00
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.43
Range1M
3.19
Range3M
4.54
Rel. volume
1.63
Price X volume
37.08M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | SLNO | Diagnostics & Research | 33.22 | 1.29B | -1.16% | n/a | 0.11% |
| Quidel Corporation | QDEL | Diagnostics & Research | 15.24 | 1.02B | -8.03% | n/a | 87.31% |
| NeoGenomics Inc | NEO | Diagnostics & Research | 7.96 | 1.02B | -2.69% | n/a | 66.22% |
| CareDx Inc | CDNA | Diagnostics & Research | 17.15 | 904.49M | -2.50% | n/a | 11.88% |
| CASTLE BIOSCIENCES INC | CSTL | Diagnostics & Research | 25 | 693.42M | -2.72% | n/a | 5.94% |
| Atossa Genetics Inc | ATOS | Diagnostics & Research | 5.33 | 670.28M | 3.90% | n/a | 0.00% |
| Personalis Inc | PSNL | Diagnostics & Research | 7.26 | 478.69M | 0.97% | n/a | 41.56% |
| Fulgent Genetics Inc | FLGT | Diagnostics & Research | 15.51 | 469.90M | -0.32% | n/a | 1.18% |
| Varex Imaging Corporation | VREX | Diagnostics & Research | 10.66 | 435.58M | -3.88% | 16.69 | 80.92% |
| Palatin Technologies Inc | PTN | Diagnostics & Research | 21.45 | 419.31M | 4.33% | n/a | -382.57% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| IMAX Corporation | IMAX | Media - Diversified | 36.69 | 1.93B | 0.19% | 54.26 | 110.44% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 10.19 | 1.83B | 0.10% | n/a | -571.93% |
| HNI Corporation | HNI | Building Products & Equipment | 33.99 | 1.60B | -1.51% | 22.12 | 76.47% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 14.35 | 1.43B | -3.37% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 37.42 | 1.18B | -2.30% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 33.41 | 967.39M | 0.97% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.25 | 762.94M | -2.23% | 11.62 | 116.21% |
| HUYA Inc | HUYA | Media - Diversified | 3.04 | 688.17M | -7.60% | n/a | 0.00% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 16.08 | 670.27M | -1.83% | 42.05 | 64.69% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.55 | 641.45M | 0.73% | 65.18 | 77.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 23.77 | 12.67 | Expensive |
| Ent. to Revenue | 4.28 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 1.00 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 73.69 | 59.59 | Riskier |
| Debt to Equity | 0.28 | -14.36 | Expensive |
| Debt to Assets | 0.20 | 0.34 | Cheaper |
| Market Cap | 1.81B | 13.71B | Emerging |